Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Quantiphi, DDReg Partner to Transform Regulatory Reporting in Life Sciences Through AI

Quantiphi (PRNewsfoto/Quantiphi Inc)

Quantiphi, a global AI-first digital engineering company and DDReg, a global leader in regulatory expertise announced a partnership that will address regulatory challenges that pharmaceutical companies, biotechnology firms, medical device and cosmetics manufacturers face by bringing innovations to market more quickly through AI.

Also Read: Segmind Adds Recraft-V3-SVG, Bringing Scalable Vector Graphics to Its Creative Platform

Quantiphi Global Head of Healthcare and Life Sciences Barinder Marhok said the partnership marries DDReg’s expertise in global regulatory process management and securing and renewing government approvals for healthcare interventions with Quantiphi’s expertise in AI-managed processes and documents.

Related Posts
1 of 41,155

“As the life sciences industry grapples with the ever-evolving regulation landscape, Quantiphi and DDReg have come together to help deliver cutting-edge solutions that streamline regulatory processes across both the drug development and commercialization lifecycle, ultimately helping improve more lives,” Marhok said. “Leveraging cloud, data and AI technologies, our joint efforts aim to accelerate approvals, enhance compliance and optimize Life Cycle Management (LCM), ensuring a faster and more efficient path to market.”

DDReg Managing Director Neeti Pant said “Our collaboration harnesses DDReg’s unparalleled regulatory knowledge and Quantiphi’s innovative technology, along with a deep understanding of artificial intelligence to revolutionize regulatory processes. Together, we are transforming how the life sciences sector navigates some of its most pressing regulatory challenges, ensuring compliance, enhancing safety and accelerating the time to market for new therapies. This collaboration will not only address current regulatory demands but also anticipate future needs, providing a framework for sustainable growth and innovation. By combining our strengths, we are paving the way for a more streamlined, effective, proactive and cost-efficient approach to regulatory affairs in the life sciences industry.”

Also Read: How Amazon, Starbucks, Tesco and Carrefour Use AI in Retail

[To share your insights with us as part of editorial or sponsored content, please write to psen@itechseries.com]

Comments are closed.